Yingu Pharmaceutical

Company Deals

Henan Lingrui to Acquire Yingu Pharma for RMB 704 Million

Fineline Cube Feb 6, 2025

China’s Henan Lingrui Pharmaceutical Co., Ltd. (SHA: 600285) announced plans to acquire a 90% ownership...

Company Deals

Shandong Saito Biotech to Acquire Majority Stake in Yingu Pharmaceutical

Fineline Cube Oct 16, 2023

China-based Shandong Saito Bio-Technology Co., Ltd. (SHE: 300583) has announced plans to acquire a 60%...

Company Drug

Nanjing King-Friend Bio’s Biosimilar Victoza Approved by FDA

Company Drug

Bio-Sincerity Pharma-tech Gains NMPA Approval for BIOS-0618 in Obstructive Sleep Apnea

Company Deals

Duality Biotherapeutics Makes Hong Kong IPO Debut with ADC Pipeline

Company Drug

Santen’s Tapcom Approved by China’s NMPA for Glaucoma Treatment